Chronic Kidney Disease

Market opportunity for Chronic Kidney Disease

  • Chronic kidney disease (CKD) is defined as the presence of kidney damage or an estimated glomerular filtration rate (eGFR) less than 60 ml/min/1.73 mt2, 
  • It is a state of usually progressive loss of kidney function resulting in many cases in the need for renal replacement therapy (dialysis or transplantation).
  • Characteristic of CKD include Albuminuria, Hypertension, Cardiac Hypertrophy, Anemia and Hyperkalemia
  • More than1 in 7 U.S. adults have CKD
  • In 2016, nearly 125,000 people in the United States started treatment for ESRD
  • The global end stage renal disease market size is anticipated to reach USD $172.0 billion by 2027, exhibiting a CAGR of 12.4% over the forecast period

There are studies underway in the mouse model of CKD caused by kidney oblation. These studies are aimed at examining the mechanism of action and will be presented at the 2020 meeting of the American Society of Nephrology